Steve Bannon Accidentally Revealed 'Secret' Trump Plan?

With one executive order, Trump could dismantle the rigged financial system--and return America to the gold standard. He's been stockpiling gold since 1974... should you? Discover the "Trump Loophole" to move funds from your IRA & 401(k) into gold--tax free!

Eventful Monday For AstraZeneca - What's Going On?

Vandana Singh
March 17, 2025

On Monday, AstraZeneca Plc (NASDAQ:AZN) released high-level results from the CALYPSO Phase 3 trial designed to evaluate the efficacy and safety of eneboparatide in adults with chronic hypoparathyroidism.

The study showed that eneboparatide (AZP-3601), an investigational parathyroid hormone (PTH) receptor 1 agonist, met its primary endpoint with statistical significance at 24 weeks in adults with chronic hypoparathyroidism (HypoPT) compared to placebo.

The primary endpoint is a composite of normalization of albumin-adjusted serum calcium levels and independence from active vitamin D and oral calcium therapy.

Also Read: AstraZeneca’s Imfinzi-Based Regimen Shows Improved Event-Free Survival In Early-Stage Gastric Cancer Patients

HypoPT is a rare endocrine disease caused by a deficiency of PTH and is characterized by impaired regulation of calcium and phosphate levels in the blood. Eneboparatide was well tolerated.

After the 24-week randomized treatment period, all patients receive eneboparatide in the ongoing long-term extension until 52 weeks. Full efficacy and safety data will be analyzed at 52 weeks.

Concurrently, AstraZeneca and Alteogen entered into an exclusive license agreement for ALT-B4, a hyaluronidase utilizing Hybrozyme platform technology.

Under the terms of the agreement, AstraZeneca will acquire worldwide rights to use ALT-B4 to develop and commercialize subcutaneous formulations of several oncology assets.

Alteogen will be responsible for the clinical and commercial supply of ALT-B4 to AstraZeneca.

AstraZeneca will pay Alteogen an upfront payment and additional payments upon achieving specific development, regulatory, and sales-related milestones. Additionally, Alteogen will receive royalties on the sales of the commercialized products.

On Monday, the European Union approved AstraZeneca’s Imfinzi (durvalumab) as monotherapy for adults with limited-stage small cell lung cancer whose disease has not progressed following platinum-based chemoradiation therapy.

The approval is based on results from the ADRIATIC Phase 3 trial.

The trial showed that Imfinzi reduced the risk of death by 27% compared to placebo.

The estimated median overall survival was 55.9 months for Imfinzi versus 33.4 months for placebo. An estimated 57% of patients treated with Imfinzi were alive at three years compared to 48% for placebo.

Imfinzi also reduced the risk of disease progression or death by 24% versus placebo.

The median progression-free survival (PFS) was 16.6 months for Imfinzi versus 9.2 months for placebo. An estimated 46% of patients treated with Imfinzi had not experienced disease progression at two years compared to 34% for placebo.

Earlier on Monday, AstraZeneca agreed to acquire cell therapy focused-EsoBiotec SA for up to $1 billion.

Price Action: At the last check on Monday, AZN stock was down 1.04% to $76.78 during the premarket session.

Read Next:

  • Hain Celestial Valuation Is Low Versus Historical Levels, But Analyst Remains Neutral – Here’s Why

Image by Robert Way via Shutterstock

Continue Reading...

Popular

Small Plane Crashes In Pennsylvania Retirement Facility Parking Lot After Pilot Reports 'Open Door'

A Beechcraft Bonanza carrying five people crashed Sunday afternoon near a retirement village south of Lancaster Airport in Pennsylvania, according to Federal Aviation Administration officials. All passengers survived and were transported to hospitals for treatment.

The $20 Trillion Secret of Room 3330 - Ad

Developed by the U.S. military 79 years ago, this controversial technology is about to change American life forever: Elon Musk has already funneled $6 billion to resurrect this covert project -- and the companies involved are minting 10,000 millionaires every week [Goldman Sachs].

Trump's tariff tactics carry higher economic risks than during his first term

WASHINGTON (AP) — When Donald Trump started the biggest trade war since the 1930s in his first term, his impulsive combination of threats and import taxes on U.S. trading partners created chaos, generated drama -- and drew criticism from mainstream economists who favor free trade.

Europe-Based UCB's Bimzelx Data Reveals Sustained Skin Clearance In Inflammatory Skin Disorders

UCB's Bimzelx shows sustained efficacy in psoriasis and hidradenitis suppurativa, with high skin clearance rates and improved symptoms over long-term trials.

Trump's Economic Plan Is Driving a "Golden Anomaly" in Tiny Gold Miners - Ad

Trump's plan to revalue gold and decrease the US debt burden is causing a major dislocation in four small gold miners. Some 30 million ounces of gold have left London for the US. If you want to know why - and why four little-known gold miners are up 136% in just the last 12 months while major gold ETFs have barely moved...

Canada incoming PM says he'll keep tariffs in place until US shows respect and commits to free trade

TORONTO (AP) — Incoming said Tuesday that his government will keep tariffs in place until Americans show respect and commit to free trade after U.S. President Donald Trump threatened historic financial devastation for Canada.

Tesla Chair Robyn Denholm Sells Over $30 Million Worth Of Stock As Automaker Grapples With Macroeconomic Uncertainties, Increased Competitive Heat

Tesla Inc. Chair Robyn Denholm has sold approximately $33.7 million worth of the electric vehicle maker's stock, according to a filing with the U.S. Securities and Exchange Commission on Monday. The sale involved 112,390 shares, the same amount she offloaded last month for gross proceeds of around $43.2 million.

New Study: 50 Stocks Will Crash While 7 MAGA Stocks Will Soar - Ad

If you own any of these stocks -- directly or through mutual funds -- I want to encourage you to sell them before April 30th. I've compiled all 50 companies in my "MAGA Blacklist" report. Your retirement could depend on seeing this list.

Mortgage lender Rocket Cos. to acquire real estate brokerage Redfin in deal valued at $1.75 billion

Mortgage lender Rocket Cos. has agreed to acquire online real estate brokerage Redfin in an all-stock deal valued at $1.75 billion.

AI pioneers who channeled 'hedonistic' machines win computer science's top prize

Teaching machines in the way that animal trainers mold the behavior of dogs or horses has been an important method for developing artificial intelligence and one that was recognized Wednesday with the top computer science award.

Debts, Deficits & Destruction of the US Dollar - Ad

The economist Time Magazine called "out of step with economic reality" for predicting the U.S. economy would implode in his 2005 best-selling book Empire of Debt over two years before the Financial Crisis tore America and the global economy apart... is back to issue his next warning. Before you invest a single dollar in the markets -- or make any investment decisions -- it's critical you see this alarming video right away.

Iranian government official who was key to 2015 nuclear deal resigns under hard-liner pressure

TEHRAN, Iran (AP) — A former Iranian foreign minister who was key to the country's 2015 nuclear deal with world powers reportedly tendered his resignation on Monday from the government of reformist , caving in to pressure from hard-liners.

Analyst Sees Wendy's Playing Catch-Up, Needs Stronger Focus on Tech, Talent & Global Expansion

J.P. Morgan analyst Rahul Krotthapalli maintains a Neutral rating on Wendy's with a $17 price target. Despite its strong U.S. presence, Wendy's faces a sub-1x sales/investment ratio.

Why Trump's Recent Moves Could Ignite a New Gold Standard - Ad

Donald Trump's bold policies are driving a hidden gold market boom. Garrett Goggin, a renowned precious metals expert with 20+ years of experience, reveals 5 explosive investment opportunities set to explode in this new era. Backed by triple-digit returns in 2024, Garrett's insights show you how to position yourself for wealth in 2025.

Freshpet Is Not Out Of The Woods On Consumption Trends, Analyst Says

JP Morgan analyst cuts Freshpet price forecast to $102 while maintaining a Neutral rating. Concerns over changing consumption trends and accuracy of estimates, but strong revenue growth and long-term potential. EBITDA and revenue growth estimates revised.

Trump is buying a Tesla. A look at the harsh things he's had to say about EVs over the years

WASHINGTON (AP) — President Donald Trump, who's to show loyalty to company CEO , has had plenty to say about electric vehicles over the years. Most of it is not good.

The DOGE Shock: Nine Stocks to Buy - Ad

They say that DOGE's real agenda could shock the entire stock market in the coming days - sending a handful of widely unknown stocks soaring. And they've compiled the definitive investment playbook for anyone who wants the opportunity to capitalize.

Prices rose along border ahead of Trump's tariffs - now disruption looms

As are set to take effect on Tuesday, Hispanic-owned businesses and companies that depend on cross-border trade are already passing higher prices onto consumers and preparing to sharply reduce imports.

Why should America worry about Trump? Try the price of eggs, say some Democrats

NEW YORK (AP) — As their party struggles to navigate the early days of Donald Trump's second presidency, some Democrats are convinced that their road to recovery lies in the price of eggs.

The 2025 'Trump Shock' [401K Owners Stunned] - Ad

Trump's Gold Reset? A massive dollar overhaul could be coming! Insiders say Trump may return America to the gold standard--sending gold prices soaring. He's been stockpiling gold for decades... should you? Discover how to legally move funds from your IRA & 401(k) into gold tax-free!

Asian shares decline despite rebound on Wall St as investors await next steps in trade wars

BANGKOK (AP) — Asian shares were mostly lower on Thursday despite a rebound on Wall Street fueled by an on U.S. consumer prices.

Kentucky bourbon makers fear becoming 'collateral damage' in Trump's trade war

LOUISVILLE, Ky. (AP) — With a new distillery set to open soon, the makers of Brough Brothers bourbon in Kentucky were ready to put their business plan into action. They were looking to ramp up whiskey production to break into lucrative new markets in Canada and Europe.

What should you be doing to "AI-Proof" your retirement? - Ad

AI is creeping into every aspect of our daily lives... According to billion-dollar fund manager Louis Navellier, it's never been more important to AI-proof your wealth. He lays out three simple steps to take ASAP in his new video.

NASCAR countersues 23XI and Front Row, as well as Michael Jordan's agent, in dispute over charters

CHARLOTTE, N.C. (AP) — NASCAR on Wednesday filed a counterclaim against Michael Jordan-owned 23XI Racing and Front Row Motorsports alleging they “willfully” violated antitrust laws by orchestrating anticompetitive collective conduct in connection with the most recent charter agreements.

Three New Patents Reveal Elon and Trump's Secret "Project America" - Ad

Three patents could help President Trump and Elon Musk completely revolutionize a $23 Trillion market. This revolution is about so much more than just self-driving cars. Instead, what Elon's pivoting Tesla towards... Is a market that's 1,000X BIGGER. But a project THIS big can't stay under the radar for long...

Activist groups urge UN probe of its Myanmar envoy after report alleges ties to Chinese companies

BANGKOK (AP) — Activist groups are calling for the United Nations to investigate its special envoy to Myanmar over possible conflicts of interest, after a report detailed her consulting company's alleged ties to Chinese mining and construction projects in the country.

Gold's About to Go Parabolic? (Trump's First Term Sent It Soaring) - Ad

During President Trump's first term, tariffs & rate cuts sent gold soaring 57%. Now, Trump is using the same playbook. Are you expecting different results? Hint: Gold is now surging, and experts predict gold could hit $4,000... even $10,000! Move funds from your IRA & 401(k) into gold--TAX & PENALTY-FREE--while you still can!

Major retailers tamper expectations for 2025 as Americans slow their spending

A pullback by American shoppers has led to more caution from national retailers about their sales potential in 2025, Abercrombie & Fitch on Wednesday becoming the latest.

Why United Airlines (UAL) Stock Is Down 15% This Week

United Airlines shares are trading lower by 15% since Monday's open. The stock is down amid rising trade tensions, higher costs and global uncertainty.

Forget Nvidia - This Odd Tariff Play Is Now Going Viral - Ad

As President Trump slaps China with new tariffs, the Fed is boxed in--and gold is skyrocketing just like it did during Trump's first term. JPMorgan just grabbed $4 Billion in gold bars... should you? Discover a "Tariff Assistance Loophole" to move funds from your IRA & 401(k) into gold--tax-free!

Dollar General Q4 Earnings Preview: Revenue, Profit Margins, Tariffs In The Spotlight

Dollar General is set to release its fourth-quarter financial results ahead of Thursday's opening bell. Here's a look at what to expect in the report.

Amazon is now testing AI-aided dubbing for some movies and series on Prime

Amazon is testing artificial intelligence-aided dubbing for select movies and shows offered on its Prime streaming service.

March 20th: The NEXT 50X Nvidia Call - Ad

In 2016 Louis Navellier made a big prediction regarding Nvidia's GPUs... Its stock price was a split-adjusted $1 and went up more than 7,000% at its peak. Don't miss Louis NEXT BIG Nvidia call. (Plus 6 stocks you need to own before March 20th.)

What's Going On With IonQ Stock Today?

IonQ shares are down amid broader tech sector weakness, despite recent breakthroughs in quantum computing and participation at SXSW.

Root And ZoomInfo Are Among Top 8 Mid-Cap Gainers Last Week (Feb 24-Feb 28): Are The Others In Your Portfolio?

Top mid-cap stock gainers in past week: Root, Bridge Investment Group, Huron Consulting, Medical Properties Trust, ZoomInfo Technologies, Lantheus Holdings, Alignment Healthcare, VSE. Analysts raise price forecasts.

13-Second Trump Video Could Trigger AI Shock - Ad

Louis Navellier, the legendary investor who picked Nvidia before shares exploded as high as 3,423%... Just released a video with this 13-second Trump clip about the current AI boom. Please, do NOT buy any AI stock before watching that clip. What President Trump said in that clip could have implications for this AI boom.

Intel, D-Wave Quantum, Adobe, Nvidia, And Tesla: Why These 5 Stocks Are On Investors' Radars Today

The S&P 500 and Nasdaq rose on Wednesday. The rally was fueled by a cooler-than-expected inflation report, which bolstered expectations for monetary easing.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright technicaltrading.org
Privacy Policy | Terms of Service